A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease
暂无分享,去创建一个
Gastone G. Celesia | David A. Bennett | Norman L. Foster | John P. Blass | David S. Knopman | Charles S. Davis | Paul Tuttle | Ira R. Katz | Sonia Pawluczyk | Rachelle S. Doody | Martin R. Farlow | Norman Relkin | David Bachman | Lon S. Schneider | Clifford N. Lazarus | Paul R. Solomon | Walter Martinez | Sarah E. Bridges | Bruno Giordani | S. Harkins | L. Schneider | I. Katz | D. Bennett | P. Solomon | D. Knopman | N. Relkin | C. Sadowsky | R. Doody | N. Foster | D. Gelb | N. Earl | S. Berent | E. Rubin | M. Coats | C. Forchetti | B. Diamond | H. Hendrie | B. Giordani | G. Celesia | M. Farlow | N. Barbas | J. Blass | R. Margolin | John C. Morris | K. Nolan | L. Langley | D. Bachman | P. Winner | S. Pawluczyk | K. Edwards | W. Pendlebury | Walter Martínez | A. Levin | M. Greenwald | M. C. Burger | M. Rymer | H. Bernstein | C. Kellner | Hugh C. Hendrie | Stephen W. Harkins | Charles H. Kellner | Carl H. Sadowsky | Mildred Farmer | Amy Perrin Ross | Richard Margolin | Stephen G. Thein | Stanley Berent | M. J. Knapp | C. Davis | S. Gracon | J. Apter | Karen E. Baker | M. Barnett | B. Baumel | L. Eisner | E. Gaines | R. Borison | A. P. Ross | J. Dexter | L. Lipscomb | K. Kreiter | E. Duboff | P. Block | D. Marshall | Nancy Westergaard | S. Wyne | Elisabeth Hinman-Smith | Judith A. Caress | M. Farmer | J. Harper | J. Ferguson | L. Bluemlein | S. Bergman | L. Roger | A. Groenendyk | M. Wood | C. Jurkowski | Suzanne Doyle | B. Smith | S. Deinard | S. Wiser | C. Crenshaw | P. Reyes | Catherine Bentz | Lara L. Doyle | I. Bettinger | M. Laubinger | J. Zúñiga | R. Stone | L. Maté | Carla Lessard | Ward T. Smith | Scott N. Losk | Linda Marambe | M. Groccia-Ellison | John A. Taylor | V. Calabrese | S. Thein | J. A. Dewar | G. Williams | C. Drennan | Paul Tuttle | N. Principi | E. M. Ford | Robert J. Tyndall | C. K. Kelley | Karen A. Nolan | Douglas J. Gelb | Barry Baumel | Vincent P. Calabrese | Mary A. Coats | Eugene H. Rubin | William W. Pendlebury | Patricio F. Reyes | Margaret J. Knapp | S. I. Gracon | Jeffrey T. Apter | Michael L. Barnett | Larry S. Eisner | Concetta Forchetti | Amy Levin | Eleonore R. Gaines | Richard L. Borison | Bruce Diamond | James R. Dexter | Lisa Lipscomb | Kurt Kreiter | Eugene A. DuBoff | Paul Block | Deborah A. Marshall | Nancy Westergaard | Nancy L. Earl | Sarah Vann Wyne | Elisabeth Hinman-Smith | Jane E. Harper | James J. Ferguson | Nancy R. Barbas | Laurie A. Bluemlein | Maria Greenwald | Scott Bergman | Linda F. Roger | Adrian Groenendyk | Myrna Wood | Claire Jurkowski | Suzanne L. Doyle | Buster D. Smith | Hilary J. Bernstein | Susan Deinard | Linda K. Langley | Sarah Bridges | Mary Candice Burger | Susan Longwith Wiser | Caryn Crenshaw | Catherine Bentz | Marilyn M. Rymer | Irene E. Bettinger | M. Pat Laubinger | José Zuniga | Reed Stone | Paul Winner | Lazlo Maté | Carla Lessard | Linda Marambe | Mary Ellen Groccia-Ellison | Keith R. Edwards | Judith A. Dewar | Geri Williams | Carol Drennan | Nancy Principi | Elaine M. Ford | Connie K. Kelley | J. Morris | Buster D. Smith | B. D. Smith | L. Lipscomb | D. Knopman | J. Morris | Karen Baker | Kurt T. Kreiter | A. P. Ross | D. Bennett
[1] H. Crystal,et al. Rate of Progression of Alzheimer's Disease , 1989, Journal of the American Geriatrics Society.
[2] Gary G. Koch,et al. Average Partial Association in Three-way Contingency Tables: a Review and Discussion of Alternative Tests , 1978 .
[3] A. Kling,et al. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.
[4] L. Thal,et al. Monitoring Progression in Alzheimer's Disease , 1991, Journal of the American Geriatrics Society.
[5] B. Reisberg,et al. The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.
[6] J. S. Benton,et al. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients , 1982, Journal of the Neurological Sciences.
[7] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[8] J T Becker,et al. Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. , 1988, Archives of neurology.
[9] K. Davis,et al. Oral physostigmine treatment of patients with Alzheimer's disease. , 1985, The American journal of psychiatry.
[10] J. Coyle,et al. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.
[11] M Farlow,et al. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. , 1992, JAMA.
[12] A. Burns,et al. Progression of Cognitive Impairment in Alzheimer's Disease , 1991, Journal of the American Geriatrics Society.
[13] R DeJong,et al. Measurement of quality-of-life changes in patients with Alzheimer's disease. , 1989, Clinical therapeutics.
[14] R F Woolson,et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. , 1992, The New England journal of medicine.
[15] M. Lawton,et al. Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .
[16] L. Thal,et al. Longitudinal evaluation of dementia of the Alzheimer type , 1990, Neurology.
[17] S. Gauthier,et al. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. , 1990, The New England journal of medicine.
[18] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[19] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[20] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[21] D M Bowen,et al. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.
[22] K. Davis,et al. Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. , 1988, Psychopharmacology bulletin.
[23] L. Schneider. Tracking Dementia by the IMC and the MMSE , 1992, Journal of the American Geriatrics Society.
[24] G. Blessed,et al. NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA , 1977, The Lancet.
[25] D. Knopman,et al. Observations on the short‐term 'natural history' of probable Alzheimer's disease in a controlled clinical trial , 1994, Neurology.
[26] T. Koepsell,et al. Hearing Impairment and Cognitive Decline in Senile Dementia of the Alzheimer's Type , 1986, Journal of the American Geriatrics Society.